Submucosal Injection EMR vs. Underwater EMR for Colorectal Polyps
IvU
Submucosal Injection Assisted Endoscopic Resection vs. Underwater EMR for Large Sessile Colorectal Polyps
1 other identifier
interventional
170
1 country
1
Brief Summary
The aim of this study is to compare the efficacy and safety of two standard methods of polypectomy (polyp removal), submucosal injection-assisted endoscopic mucosal resection (EMR) and full water emersion (without submucosal injection) EMR, for large colorectal polyps.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Sep 2012
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2012
CompletedFirst Submitted
Initial submission to the registry
October 19, 2012
CompletedFirst Posted
Study publicly available on registry
October 23, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2019
CompletedFebruary 10, 2020
February 1, 2020
7.3 years
October 19, 2012
February 6, 2020
Conditions
Outcome Measures
Primary Outcomes (1)
Adenoma recurrence rate
6 months
Secondary Outcomes (2)
Adverse event rate
48 hours
Procedure time
24 hours
Study Arms (2)
Submucosal Injection EMR
ACTIVE COMPARATORFor patients who are randomized to the "submucosal injection" arm polypectomy will be performed with selective saline injection to the layer of tissue underneath the polyp in order to create a "safety cushion" for resection.
Underwater EMR
ACTIVE COMPARATORFor patients who are randomized to the "underwater" arm polypectomy with water will be performed under full water emersion without the use of submucosal injection.
Interventions
Selective saline injection is applied to the layer of tissue underneath the polyp in order to create a "safety cushion" for resection. EMR is then performed with a standard snare.
Polypectomy is performed under full water emersion without the use of submucosal injection.
Eligibility Criteria
You may qualify if:
- Patients age \>18 years that are scheduled for endoscopic resection of large colo-rectal lesions who consent to this study.
You may not qualify if:
- Patients unable to provide informed consent.
- Patients with lesions showing adenoma invasion into the muscularis propria on EUS.
- Patients without at least one colo-rectal lesions ≥ 20mm.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
California Pacific Medical Center
San Francisco, California, 94115, United States
Related Publications (5)
ROSENBERG N. Submucosal saline wheal as safety factor in fulguration or rectal and sigmoidal polypi. AMA Arch Surg. 1955 Jan;70(1):120-2. doi: 10.1001/archsurg.1955.01270070122021. No abstract available.
PMID: 13217613BACKGROUNDNorton ID, Wang L, Levine SA, Burgart LJ, Hofmeister EK, Rumalla A, Gostout CJ, Petersen BT. Efficacy of colonic submucosal saline solution injection for the reduction of iatrogenic thermal injury. Gastrointest Endosc. 2002 Jul;56(1):95-9. doi: 10.1067/mge.2002.125362.
PMID: 12085042BACKGROUNDNelson DB. Techniques for difficult polypectomy. MedGenMed. 2004 Oct 25;6(4):12. No abstract available.
PMID: 15775839BACKGROUNDZarchy T. Risk of submucosal saline injection for colonic polypectomy. Gastrointest Endosc. 1997 Jul;46(1):89-90. doi: 10.1016/s0016-5107(97)70222-0. No abstract available.
PMID: 9260717BACKGROUNDKudo S, Kashida H, Nakajima T, Tamura S, Nakajo K. Endoscopic diagnosis and treatment of early colorectal cancer. World J Surg. 1997 Sep;21(7):694-701. doi: 10.1007/s002689900293.
PMID: 9276699BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Kenneth Binmoeller, M.D.
California Pacific Medical Center
- STUDY DIRECTOR
Christopher Hamerski, M.D.
California Pacific Medical Center
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Interventional Endoscopy Program Director
Study Record Dates
First Submitted
October 19, 2012
First Posted
October 23, 2012
Study Start
September 1, 2012
Primary Completion
December 1, 2019
Study Completion
December 1, 2019
Last Updated
February 10, 2020
Record last verified: 2020-02